SAMG Share Price Performance
US$9.95
-6.60 (-39.88%)
50.3% undervalued intrinsic discount
US$20.00
Fair Value
Price US$9.95
AnalystConsensusTarget US$20.00
Fair ValueUS$20.00
Share Pricen/a
Narrative Update • Jun 24
Silvercrest Asset Management Group Inc. Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 37 Fair Values set on narratives written by author
SAMG Community Narratives
AN
Fair Value
·Fair Value US$20 50.2% undervalued intrinsic discount
Intergenerational Wealth Transfer And Global Expansion Will Unlock Future Value
0users have liked this narrative
0users have commented on this narrative
24users have followed this narrative
Intergenerational Wealth Transfer And Global Expansion Will Unlock Future Value
Silvercrest aims to ride a wave of money moving from older to younger generations, using high-touch advice and family office services to win and keep wealthy clients. But the same shift toward cheaper investing and rising costs could squeeze what it earns unless its expansion and new offerings pay off.Read more
AN
US$20
50.2% undervalued intrinsic discount
Fair Value
Revenue
4.7% p.a.
Profit Margin
11.53%
Future PE
9.17x
Price in 2029
US$24.63
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
SAMG: Atlanta Expansion Will Support Long-Term Upside
Fair Value: US$20 50.2% undervalued intrinsic discount
24 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Silvercrest Asset Management Group Inc. Key Details
About SAMG
- Founded
- 2002
- Employees
- 173
- CEO
- WebsiteView website
Silvercrest Asset Management Group Inc., a wealth management firm, provides financial advisory and related family office services in the United States. The company serves ultra-high net worth individuals and families, as well as their trusts; endowments; foundations; and other institutional investors. It also manages funds of funds and other investment funds. The company was founded in 2002 and is headquartered in New York, New York.
